Caitong International Asset Management’s Propanc Biopharma PPCB Stock Holding History

Caitong International Asset Management’s Portfolio PPCB Stock Details PPCB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3	Buy	+2	New	+$4	﹤0.01%	2815

Other funds holding PPCB

Mercer Global Advisors Denver, Colorado $80B AUM 26.12% 1-Year Est. Return

Caitong International Asset Management's PPCB Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in Propanc Biopharma (PPCB) in Q2 2026: 2 shares worth $3. The stake represents ﹤0.01% of the portfolio and ranks #2815 among its holdings.

2 funds tracked by Wall St. Rank hold PPCB as of Q2 2026.

Caitong International Asset Management held 2 shares of Propanc Biopharma worth $3 as of Q2 2026.
Propanc Biopharma was a new Caitong International Asset Management position in Q2 2026.
Propanc Biopharma made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2815 holding.
2 funds tracked by Wall St. Rank held Propanc Biopharma as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.